POAI Predictive Oncology Inc. Stock Quote

POAI [NASD]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	-	EPS (ttm)	-5.41	Insider Own	6.80%	Shs Outstand	17.68M	Perf Week	34.81%
Market Cap	27.78M	Forward P/E	-	EPS next Y	-	Insider Trans	0.42%	Shs Float	16.46M	Perf Month	78.42%
Income	-28.70M	PEG	-	EPS next Q	-	Inst Own	5.30%	Short Float	2.60%	Perf Quarter	61.04%
Sales	1.30M	P/S	21.37	EPS this Y	12.90%	Inst Trans	288.99%	Short Ratio	0.31	Perf Half Y	-28.74%
Book/sh	0.81	P/B	1.53	EPS next Y	-	ROA	-114.60%	Target Price	-	Perf Year	-61.19%
Cash/sh	0.11	P/C	11.11	EPS next 5Y	-	ROE	-252.30%	52W Range	0.63 - 5.30	Perf YTD	69.31%
Dividend	-	P/FCF	-	EPS past 5Y	58.70%	ROI	-145.20%	52W High	-76.60%	Beta	1.78
Dividend %	-	Quick Ratio	0.30	Sales past 5Y	8.20%	Gross Margin	62.90%	52W Low	96.83%	ATR	0.11
Employees	29	Current Ratio	0.30	Sales Q/Q	0.00%	Oper. Margin	-	RSI (14)	82.20	Volatility	15.49% 14.16%
Optionable	No	Debt/Eq	0.48	EPS Q/Q	65.20%	Profit Margin	-	Rel Volume	5.47	Prev Close	1.04
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	1.37M	Price	1.24
Recom	-	SMA20	55.35%	SMA50	67.30%	SMA200	6.35%	Volume	7,495,424	Change	19.23%

Jan-19-21 08:00AM	Predictive Oncology Announces $2.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules GlobeNewswire
Jan-14-21 08:30AM	Predictive Oncology Reports That Its Wholly Owned Subsidiary, TumorGenesis, Has Sold Media to Two Top Research Medical Centers GlobeNewswire
Jan-12-21 05:15PM	Predictive Oncology Announces Closing of $3.074 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire
Jan-08-21 09:00AM	Predictive Oncology Announces $3,074,007 Registered Direct Offering Priced At-The-Market under Nasdaq Rules GlobeNewswire
Jan-06-21 08:30AM	Predictive Oncologys Wholly Owned Subsidiary Helomics completes integration of Quantitative Medicine GlobeNewswire -6.46%
Jan-05-21 08:30AM	Predictive Oncology Hires Investor Relations Firm GlobeNewswire +18.04%
Dec-29-20 05:15PM	Predictive Oncology Announces Cancellation of Special Meeting in December 2020 GlobeNewswire
Dec-09-20 08:30AM	Predictive Oncology Sends Letter to Shareholders Regarding Special Meeting to be Reconvened on December 30, 2020 GlobeNewswire +8.64%
Dec-02-20 08:00AM	Predictive Oncology Announces Adjournment of Special Meeting GlobeNewswire
Nov-16-20 05:20PM	Predictive Oncology Reports Third Quarter 2020 Financial Results, Provides Business Update GlobeNewswire
Oct-27-20 08:30AM	Predictive Oncology Inc. CEO Provides Updates on Subsidiaries, Highlights Recent Milestones and Near-Term Goals GlobeNewswire
Oct-06-20 08:30AM	Predictive Oncology CEO Letter to Shareholders GlobeNewswire
Oct-02-20 12:14PM	What Can We Conclude About Predictive Oncology's (NASDAQ:POAI) CEO Pay? Simply Wall St. -5.43%
Sep-22-20 05:10PM	Predictive Oncology Secures License for an Additional 71 Unique Ovarian Cancer Cell Lines from Ximbio, Cancer Research UKs Premier Reagents Distributor GlobeNewswire
Sep-01-20 05:15PM	Predictive Oncology Inc to Present at LD Micro's "LD 500" Virtual Investor Conference on Wednesday, September 02, 2020 3:40 PM Eastern Time GlobeNewswire -14.07%
Aug-20-20 08:30AM	Soluble Biotech Announces First Contract with a Major Pharmaceutical Company for Protein Expression and Solubility Studies GlobeNewswire
Aug-18-20 08:30AM	Predictive Oncologys Skyline Medical Sells 8 STREAMWAY® Systems to a Large University Hospital Organization in Virginia; 13 STREAMWAY® Systems Sold Halfway Into Q3 2020 GlobeNewswire
Aug-14-20 08:30AM	Predictive Oncology Announces DojoLIVE! Interview with Helomics CIO Mark Collins, Can We Cure Cancer with Artificial Intelligence? GlobeNewswire
Aug-13-20 05:10PM	Predictive Oncology Reports Second Quarter 2020 Financial Results, Provides Business Update GlobeNewswire
Aug-11-20 08:30AM	Predictive Oncology Issues Letter to Shareholders GlobeNewswire -7.65%
Aug-05-20 09:00AM	LD Micro Announces Preliminary List of Presenters for the LD-500 ACCESSWIRE
Jul-14-20 08:30AM	Predictive Oncology Refreshes Board with Appointment of Three New Directors GlobeNewswire
Jul-07-20 08:15AM	Predictive Oncology Completes Acquisition of Quantitative Medicine GlobeNewswire +6.12%
Jun-29-20 04:30PM	Predictive Oncology Inc. Announces Receipt of Cash Proceeds of $2.2 Million from Exercise of Warrants GlobeNewswire
Jun-18-20 08:30AM	Predictive Oncologys TumorGenesis Division Secures First Commercial Sale of its Novel Ovarian Cancer Cell Media GlobeNewswire +15.70%
Jun-08-20 04:15PM	Predictive Oncology Reports First Quarter 2020 Financial Results, Provides Business Update GlobeNewswire +5.20%
Jun-02-20 08:30AM	Predictive Oncology Completes Acquisition of Soluble Therapeutics and BioDtech GlobeNewswire
May-14-20 08:30AM	Predictive Oncology (NASDAQ Symbol POAI) is licensing and partnering this groundbreaking NSP10 technology in the race to develop a vaccine for development GlobeNewswire
May-07-20 08:00AM	Predictive Oncology Announces $2.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules GlobeNewswire -14.00%
May-06-20 08:30AM	Predictive Oncology and Dr. Daniel Carter Collaborating to Develop a Potential COVID-19 Vaccine Utilizing Novel Nanoparticle Vaccine Platform, Based on NSP-10 GlobeNewswire
Apr-22-20 05:00PM	Predictive Oncology Exchanges $2.1 Million of Debt for Equity, Streamlining Capital Structure and Simplifying Balance Sheet GlobeNewswire
08:30AM	Predictive Oncology (NASDAQ: POAI) CEO Discusses Major Asset in Exclusive Interview GlobeNewswire
Apr-01-20 08:45AM	Predictive Oncology Reports 2019 Full-year Financial Results GlobeNewswire -11.13%
Mar-31-20 08:30AM	POAI Subsidiary Helomics Continues Progress Towards Goal of Developing an AI-Driven Predictive Model of Ovarian Cancer GlobeNewswire -13.45%
Mar-23-20 08:00AM	Predictive Oncology Inc. Announces Completion of $3.5 Million Private Placement GlobeNewswire
Mar-16-20 09:00AM	Predictive Oncology Inc. Announces $3.5 Million Private Placement GlobeNewswire -17.20%
Mar-12-20 08:30AM	Predictive Oncology Launches New AI Platform for Vaccine and Drug Development Targeting Coronaviruses and Acute Respiratory Syndromes (COVID-19, MERS, and SARS) GlobeNewswire +6.54%
Mar-02-20 08:30AM	Predictive Oncology Provides Acquisition Update, Stresses Importance of AI in New Anti-Cancers, Anti-Virals and Vaccines GlobeNewswire +13.27%
Feb-21-20 08:30AM	Predictive Oncology Inc. Appoints Dan Handley, M.S., Ph.D. to Board of Directors GlobeNewswire
Feb-07-20 02:05PM	The Best Way To Train Your Trading Muscles Benzinga -8.37%
Feb-05-20 08:30AM	Predictive Oncology Launches Innovative Specialty Media for Growing Ovarian Tumors in the Lab GlobeNewswire +12.04%
Jan-24-20 12:30PM	Predictive Oncology Inc. Signs Letter of Intent to Acquire Quantitative Medicine (qtmed.com) and an AI Engine (CoRE) that Facilitates Accelerated Drug Discovery and Development GlobeNewswire
Jan-06-20 09:00AM	Predictive Oncology Inc. Appoints Pam Prior to Board of Directors GlobeNewswire +7.30%
Dec-17-19 08:30AM	Predictive Oncology Inc. Announces Extension Of Promissory Note Due December 31, 2019 GlobeNewswire -5.90%
Dec-09-19 08:30AM	Predictive Oncology Provides Updates on Commercialization of Its Cancer Quest 2020 Initiative GlobeNewswire
Dec-05-19 08:30AM	Predictive Oncology Confirms Indications of Interest for Skyline Medical Business GlobeNewswire +6.38%
Nov-25-19 08:30AM	Predictive Oncology Has Regained Compliance with Nasdaqs Minimum Bid Price Requirement GlobeNewswire -5.02%
Nov-20-19 08:30AM	Predictive Oncology Secures $15,000,000 Equity Line GlobeNewswire
Nov-19-19 08:30AM	Predictive Oncology CEO Discusses Corporate Milestones, Unique Approach to Cancer Research in Exclusive Broadcast GlobeNewswire -5.13%
Nov-15-19 05:10PM	Predictive Oncology Inc. Reports Q3 Results; Revenues Increase 58% GlobeNewswire -5.76%
Nov-07-19 08:30AM	Predictive Oncology Featured in Broadcast Evaluating Targeted Cancer Therapies, Higher Survival Rates GlobeNewswire -5.36%
Nov-06-19 08:30AM	Predictive Oncology Featured in Publication Discussing the Impact of Artificial Intelligence on Cancer Treatment GlobeNewswire
Oct-31-19 08:30AM	Predictive Oncology Reaches First Milestone in Building AI-driven Predictive Models of Ovarian Cancer GlobeNewswire -8.83%
08:30AM	Predictive Oncology (NASDAQ: POAI) Featured in Broadcast on Big Data, AIs Potential to Fight Cancer GlobeNewswire
Oct-30-19 08:30AM	Predictive Oncology (NASDAQ: POAI) Featured in NetworkNewsWire Publication Discussing Power of Data Plus AI in Precision Medicine GlobeNewswire
Oct-24-19 08:30AM	Predictive Oncology: Helomics to present initial findings from its analysis of UK 100,000 Genomes Project data towards its goal of building AI-driven predictive models of ovarian cancer GlobeNewswire
Oct-02-19 09:57AM	Skyline Medical, a Division of Predictive Oncology Inc. (POAI), Sells 10 STREAMWAY® Systems to Prominent Teaching Hospital GlobeNewswire -9.91%
08:27AM	Predictive Oncology Inc. Announces Pricing of Public Offering of Up to $3,167,768.50 of Common Stock GlobeNewswire
08:00AM	Predictive Oncology Inc. (POAI) Sells 10 STREAMWAY® Systems to Prominent Teaching Hospital GlobeNewswire
Oct-01-19 05:45PM	Predictive Oncology Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire +9.90%
Sep-30-19 01:00PM	Predictive Oncology Inc. Announces Repayment or Extension of Promissory Notes due September 28, 2019 GlobeNewswire -14.42%
Sep-19-19 08:30AM	Coverage Initiated for Predictive Oncology via NetworkNewsWire GlobeNewswire
Aug-19-19 08:00AM	Predictive Oncology to Report Second Quarter 2019 Financial Results and Provide Company Update on Monday, August 19, 2019 GlobeNewswire
Aug-15-19 05:00PM	Predictive Oncology to Report Second Quarter 2019 Financial Results and Provide Company Update on Monday, August 19, 2019 GlobeNewswire
Aug-06-19 08:00AM	Predictive Oncologys Skyline Medical Division Expands Its Asian Market Share with First-Ever Orders of STREAMWAY Systems in India GlobeNewswire +5.02%
Jul-18-19 08:00AM	Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data and Artificial Intelligence-Driven Approach to Treating Ovarian Cancer GlobeNewswire -5.79%
Jun-26-19 08:00AM	Predictive Oncology Subsidiary, Helomics, Signs Collaborative Research Agreement with ChemImage to Expand Personalized Medicine to Prostate Cancer Prognosis and Treatment GlobeNewswire +21.16%

Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company operates in three segments: Domestic, International, and Helomics. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers' exposure to infectious fluids collected during surgical and other patient procedures, as well as provides proprietary cleaning fluid and filters for use with STREAMWAY System. The company also provides data and artificial intelligence (AI) driven contract research organization (CRO) services for clinical and translational research; a range of multi-omics assays; and AI driven predictive models for the discovery of targeted therapies. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence applied to diseases databases. The company sells its medical device products directly to hospitals and other medical facilities through employed sales representatives, independent contractors, and distributors. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was founded in 2002 and is based in Eagan, Minnesota.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schwartz Carl I.	Chief Executive Officer	Oct 22	Sale	0.85	640	544	1,611,341	Oct 26 05:38 PM
GABRIEL RICHARD L	Director	Sep 01	Buy	0.90	4,000	3,602	12,070	Sep 02 03:52 PM
GABRIEL RICHARD L	Director	Aug 19	Buy	1.18	3,000	3,527	8,070	Aug 21 04:09 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience